Abhirami Nair

ORCID: 0009-0007-0355-9933
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Tuberculosis Research and Epidemiology
  • Pneumonia and Respiratory Infections
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Healthcare Systems and Practices
  • AI in Service Interactions
  • Medication Adherence and Compliance
  • IoT and Edge/Fog Computing
  • Peripheral Neuropathies and Disorders
  • Mobile Health and mHealth Applications
  • Ocular Diseases and Behçet’s Syndrome
  • Birth, Development, and Health
  • Assisted Reproductive Technology and Twin Pregnancy
  • Ethics and Social Impacts of AI
  • User Authentication and Security Systems
  • Digital Transformation in Industry
  • Child and Adolescent Health
  • Wireless Body Area Networks
  • Multiple Sclerosis Research Studies
  • HIV/AIDS Impact and Responses

Post Graduate Institute of Medical Education and Research
2024

Framingham State University
2023

Manipal Academy of Higher Education
2020-2021

Kasturba Medical College, Manipal
2019-2021

Background: Despite many advancements in antenatal health care, twin pregnancies encounter more unfavourable outcomes as multiple pregnancy has always been associated with increased risk of fetomaternal complications particular prematurity and perinatal morbidity. Rate gestation varies significantly among different societies geographical region, however escalating use assisted reproductive techniques maternal age the incidence gestations is surging. This study was conducted an objective to...

10.18203/2320-6012.ijrms20250247 article EN International Journal of Research in Medical Sciences 2025-01-30

Background: Delays in initiating multidrug-resistant tuberculosis (MDR TB) treatment adds risk to individual patients and the community due disease progression, on-going transmission. The Government of India offers free TB diagnosis treatment, however many presumptive MDR wander within Indian healthcare system delay accessing programme. To better improve access care, it is imperative understand pathways taken by patients. We aimed describe diagnostic pathway registered Programmatic...

10.12688/f1000research.17743.1 preprint EN cc-by F1000Research 2019-04-16

<ns3:p><ns3:bold>Background</ns3:bold>: Delays in initiating multidrug-resistant tuberculosis (MDR TB) treatment adds risk to individual patients and the community due disease progression, on-going transmission. The Government of India offers free TB diagnosis treatment, however many presumptive MDR wander within Indian healthcare system delay accessing programme. To improve access care, it is imperative understand pathways taken by patients. We aimed describe diagnostic pathway registered...

10.12688/f1000research.17743.3 preprint EN cc-by F1000Research 2020-05-27

<ns3:p><ns3:bold>Background</ns3:bold>: Delays in initiating multidrug-resistant tuberculosis (MDR TB) treatment adds risk to individual patients and the community due disease progression, on-going transmission. The Government of India offers free TB diagnosis treatment, however many presumptive MDR wander within Indian healthcare system delay accessing programme. To improve access care, it is imperative understand pathways taken by patients. We aimed describe diagnostic pathway registered...

10.12688/f1000research.17743.4 preprint EN cc-by F1000Research 2020-07-22

<ns3:p><ns3:bold>Background</ns3:bold>: Delays in initiating multidrug-resistant tuberculosis (MDR TB) treatment adds risk to individual patients and the community due disease progression, on-going transmission. The Government of India offers free TB diagnosis treatment, however many presumptive MDR wander within Indian healthcare system delay accessing programme. To improve access care, it is imperative understand pathways taken by patients. We aimed describe diagnostic pathway registered...

10.12688/f1000research.17743.2 preprint EN cc-by F1000Research 2020-05-13

<ns3:p><ns3:bold>Background</ns3:bold>: Delays in initiating multidrug-resistant tuberculosis (MDR TB) treatment adds risk to individual patients and the community due disease progression, on-going transmission. The Government of India offers free TB diagnosis treatment, however many presumptive MDR wander within Indian healthcare system delay accessing programme. To improve access care, it is imperative understand pathways taken by patients. We aimed describe diagnostic pathway registered...

10.12688/f1000research.17743.5 preprint EN cc-by F1000Research 2021-07-08
Coming Soon ...